遊離（1）30 mlの細菌性水
資格のある注文があります500米ドル.
（カプセル製品、化粧品ペプチド、プロモーションコード、出荷を除く）
GHRP-2は、グレリン/成長ホルモンセクレクター受容体に結合する合成成長ホルモンセクターゴーグです。筋肉の成長を改善し、免疫系を調節し、睡眠サイクルを改善するための研究試験で示されています。 GHRP-2の研究では、経口生物活性があることが示されています。
製品の使用：この製品は、研究化学物質としてのみ意図されています。この指定により、in vitroテストと実験室の実験のために、研究化学物質を厳密に使用することができます。このウェブサイトで利用可能なすべての製品情報は、教育目的のみを目的としています。あらゆる種類の人間や動物への身体導入は、法律によって厳密に禁じられています。この製品は、認可された資格のある専門家によってのみ処理される必要があります。この製品は薬物、食品、または化粧品ではなく、薬物、食品、化粧品として誤ってブランド化されたり、誤用されたり、誤ったりしたりすることはない場合があります。
GHRP-2（A.K.A。Pralmorelin）は、グレリン/成長ホルモンセクレクター受容体に結合することが知られている合成成長ホルモンセクターゴーグです。これは、成長ホルモンの欠乏症と二次副腎不全の評価のためのテストペプチドとして現在導入された成長ホルモンの秘書の最初のものでした。 GHRP-2は、短い身長の評価に関するIIステージ臨床試験で調査されており、食欲、筋肉の成長、免疫系、睡眠サイクルに対する影響について積極的な研究を行っています。 GHRP-2は口頭で舌下で活動的であるため、その効果を発生させるために注入する必要はありません。
ソース：パブ
順序：d-ala-d-2nal-ala-ala-trp-d-phe-lys
分子式：c45h55n9o6
分子量：817.9749 g/mol
Pubchem cid： 6918245
CAS番号：158861-67-7
コード名：KP-102、GPA-748、Way-GPA-748
YAKSの研究は、GHRP-2がタンパク質沈着の増加とタンパク質分解の減少という2つの方法で筋肉の成長を上げることができることを示しています。この研究は、GHRP-2が食物の剥離、病気、環境不利益のためにヤックで発生する自然の成長高原を克服できることを示しました（例：寒さ）[1]. The most profound finding from this study is that GHRP-2 reduces muscle atrophy by inactivating atrogin-1 and MuRF1, proteins that control the muscle degradation pathway[2]. There is hope that these findings could be used to reduce the catabolism common in chronic illnesses like autoimmune disease, cancer, and more.
Of course, by activating growth hormone and insulin-like growth factor-1, GHRP-2 helps to boost muscle protein deposition. The combined effect of reducing degradation and enhancing deposition is that GHRP-2 encourages the development of lean body mass even in adverse conditions[3].
GHRP-2 has been shown to boost food intake[4], [5]. Though this may not seem acutely important, appetite stimulation in the setting of chronic disease is an important part of overall health care. The ability to easily and reliably stimulate appetite could help doctors treat chronically ill patients and improve long-term outcomes.
Food intake in healthy adult men, placebo versus GHRP-2
Source: PubMed
Research in fetal heart cell culture lines shows that GHRP-2 and its analogues (GHRP-1 and GHRP-6) can help to protect heart cells by reducing apoptosis or programmed cell death[6]. This is of particular importance following heart attack, when heart cells are particularly prone to apoptosis thanks to decreased blood and thus nutrient supply. Research using an analogue of GHRP-2 called Hexarelin has indicated that there may be a specific receptor for these peptides[7]. Identifying new receptors in any tissue opens pathways for new drug development, but also deepens our understanding of the human physiology and how to prevent dysfunction in the first place.
GHRP-2 has been shown to stimulate the thymus, an organ responsible for protecting certain cells of the immune system. In particular., the thymus helps T cells to mature. T cells are critical for adaptive immunity and our ability to fight off complex infections. Function of the thymus declines with age, which leads to a number of age-related dysfunctions ranging from inadequate tissue repair to lost immunity and thus an inability to fight off infections, guard against cancer, and maintain normal tissue function. GHRP-2 has been shown to rejuvenate the thymus, boosting the number and diversity of T-cells it produces[8]. This leads to improved immunity.
Change in number of active T-cells following administration of GHRP-2
Source: PubMed
GHRP-2 has been shown to increase the duration stages 3 and 4 of the sleep cycles by about 50% each while increasing REM sleep by approximately 20% while reducing the amount that an individual deviates from “normal sleep” by as much as a third. Overall, the improvement in sleep led to improvement in cognitive function, blood pressure, healing, and energy levels[9]. These findings, while useful to all adults, are particularly important in the elderly, where the effects of aging take a toll on sleep quality. GHRP-2 may be useful in understanding how to fine-tune sleep to improve quality and maybe even help people get all the benefits of a full night’s sleep in a fraction of the time.
It was originally thought that observations of decreased pain in animal models of osteoarthritis were the result of GHRP-2 boosting growth hormone levels and accelerating healing in the damaged tissues. Keen scientists observed, however, that the pain relief preceded healing by a substantial margin, suggesting that GHRP-2 may have direct effects on pain perception. As it turns out, GHRP-2 has action at the opioid receptors[10].
There are four known opioid receptors. Most opioid pain medications do not discriminate between them. This is problematic because while some of the receptors mediate pain, others affect things like wakefulness and breathing while still others impact addiction. GHRP-2 is a selective opioid receptor agonist, binding primarily to the receptors responsible for pain relief, sedation, and addiction. This finding indicates that it may be possible to produce selective opioid agonists and therefore mitigate or prevent entirely undesirable effects like respiratory depression and addiction.
GHRP-2 exhibits minimal to moderate side effects, low oral and excellent subcutaneous bioavailability in mice. Per kg dosage in mice does not scale to humans. GHRP-2 for sale at
The above literature was researched, edited and organized by Dr. Logan, M.D. Dr. Logan holds a doctorate degree from Case Western Reserve University School of Medicine and a B.S. in molecular biology.
Jean-Alain Fehrentz was born in Nancy, France, in 1955. He received his Ph.D. degree in Chemistry from the University of Nancy in 1983 and joined the Centre CNRS-INSERM de Pharmacologie Endocrinologie of Montpellier in the research group of Professor B. Castro. From 1989 to 1992 he was appointed as researcher at Sanofi Research in Montpellier. Then he moved to the Faculty of Pharmacy of Montpellier, working under the direction of Professor J. Martinez. His research interests focus onpeptide aldehydes, enzyme inhibitors, peptidomimetics, growth hormone interactions, and heterocycle based receptor ligands. He has published more than 150 scientific papers.
Jean-Alain Fehrentz is being referenced as one of the leading scientists involved in the research and development of GHRP-2. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
PeptideGurus is a leading supplier of American-made research peptides, offering top-quality products at competitive prices. With a focus on excellence and customer service, they ensure a secure and convenient ordering process with global shipping.
CONTACT
